MusicRadar’s roundup spotlights five software synths that challenge traditional subtractive synthesis with methods ranging from additive resynthesis to organic growth models. The lineup includes ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...
Support for Xilinx's low-cost, high-volume Spartan-3A family of I/O-optimized FPGAs is now offered by Synplicity's Synplify Pro FPGA synthesis software. The Synplify Pro FPGA synthesis tool helps ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
Software features single-pass design flow and improved timing accuracy Synplify Premier synthesis software offers FPGA designers an integrated environment that features improved routing definition ...